Skip to main content
. 2016 Jul 11;13:25. doi: 10.1186/s12981-016-0109-8

Table 3.

Unadjusted and adjusted models for predictors of ≥90 day unstructured treatment interruption across 33 MSF sites providing ART care

Predictor Level Unadjusted hazard ratio (95 % CI) p value Adjusted hazard ratio (95 % CI) p value
Sex Female Ref. Ref.
Male 0.94 (0.90–0.98) <0.01 0.94 (0.90–0.98) <0.01
Age <20 Ref. Ref.
20–39 0.81 (0.74–0.89) <0.01 0.87 (0.79–0.96) <0.01
40–59 0.79 (0.71–0.87) <0.01 0.86 (0.78–0.96) <0.01
60+ 0.86 (0.67–1.11) 0.26 1.07 (0.82–1.39) 0.61
WHO stage at ART initiation 1 Ref. Ref.
2 1.07 (0.98–1.17) 0.15 1.03 (0.95–1.13) 0.47
3 1.12 (1.05–1.21) <0.01 1.10 (1.02–1.18) <0.01
4 1.23 (1.14–1.33) <0.01 1.21 (1.12–1.30) <0.01
CD4 count at ART initiation* (cells/μL) <200 Ref. Ref.
200–350 0.87 (0.82–0.93) <0.01 0.89 (0.83–0.95) <0.01
>350 0.86 (0.78–0.95) <0.01 0.87 (0.78–0.96) <0.01
Marital status Not married Ref. Ref.
Married 0.97 (0.93–1.01) 0.18 1.02 (0.97–1.06) 0.48
Region Africa Ref. Ref.
Asia 0.79 (0.75–0.83) <0.01 0.82 (0.78–0.87) <0.01

* Individuals with missing CD4 counts were modelled as having missing data and not excluded from the analysis. Compared to the reference group (CD4 count <200) the aHR for those with missing CD4 data was 0.99 (0.94–1.03) p = 0.57